Advancing quantitative PCR with color cycle multiplex amplification.

Area of Science:

• Molecular Biology
• Biotechnology
• Medical Diagnostics

Background:

• Quantitative PCR (qPCR) is a standard for DNA detection but is limited by the number of available distinct fluorophores and filter sets.
• Multiplexing in qPCR is crucial for detecting multiple targets simultaneously, but current methods face limitations in scalability.

Purpose of the Study:

• To introduce Color Cycle Multiplex Amplification (CCMA) for significantly increasing the number of detectable DNA targets in a single qPCR reaction.
• To demonstrate CCMA's potential for advanced quantitative screening in molecular diagnostics using standard instrumentation.

Main Methods:

• CCMA utilizes pre-programmed fluorescence increase patterns, distinguished by cycle thresholds (Cts) and amplification delays, to identify specific DNA targets.
• A CCMA assay was designed where Staphylococcus aureus sequentially induced FAM, Cy5.5, and ROX fluorescence signals with distinct cycle threshold delays.
• The method leverages fluorescence permutation, theoretically allowing detection of up to 136 DNA targets with 4 distinct colors.

Main Results:

• A single-tube CCMA qPCR assay successfully screened 21 sepsis-related bacterial DNA targets from various clinical sample types (blood, sputum, pleural effusion, bronchoalveolar lavage fluid).
• The experimental CCMA assay achieved 89% clinical sensitivity and 100% clinical specificity.
• CCMA demonstrated a significantly higher potential for multiplexing compared to traditional combination-based approaches.

Conclusions:

• CCMA substantially increases the number of detectable DNA targets in a single qPCR reaction using standard equipment.
• This technique offers a powerful tool for advanced quantitative screening in molecular diagnostics, particularly for complex infectious diseases.
• CCMA's fluorescence permutation strategy overcomes limitations of current multiplexing technologies.